MAP2K7 and nasopharyngeal carcinoma: Our previous results also demonstrated that BRD7 inhibits G1/S progression, induces apoptosis, and reverses malignant behaviors in NPC cells through the Ras/MEK/ERK [31], Rb/E2F [12] and PI3K/AKT signaling pathways [15, 32].